Carbapenem Resistance, Initial Antibiotic Therapy, and Mortality in Klebsiella pneumoniae Bacteremia: A Systematic Review and Meta-Analysis

被引:102
|
作者
Kohler, Philipp P. [1 ,2 ,3 ]
Volling, Cheryl [1 ]
Green, Karen [1 ]
Uleryk, Elizabeth M. [1 ,4 ]
Shah, Prakesh S. [1 ,2 ]
McGeer, Allison [1 ,2 ]
机构
[1] Mt Sinai Hosp, Toronto, ON, Canada
[2] Univ Toronto, Inst Hlth Policy Management & Evaluat, Toronto, ON, Canada
[3] Cantonal Hosp St Gallen, Clin Infect Dis & Hosp Epidemiol, Rorschacher Str 95, CH-9007 St Gallen, Switzerland
[4] EM Uleryk Consulting, Mississauga, ON, Canada
基金
瑞士国家科学基金会;
关键词
BLOOD-STREAM INFECTIONS; MULTIDRUG-RESISTANT; BETA-LACTAMASE; K.-PNEUMONIAE; RISK-FACTORS; IMPACT; EPIDEMIOLOGY; OUTCOMES; PREDICTORS; SPREAD;
D O I
10.1017/ice.2017.197
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
BACKGROUND Mortality associated with infections caused by carbapenem-resistant Enterobacteriaceae (CRE) is higher than mortality due to carbapenem-sensitive pathogens. OBJECTIVE To examine the association between mortality from bacteremia caused by carbapenem-resistant (CRKP) and carbapenem-sensitive Klebsiella pneumoniae (CSKP) and to assess the impact of appropriate initial antibiotic therapy (IAT) on mortality. DESIGN Systematic review and meta-analysis METHODS We searched MEDLINE, EMBASE, CINAHL, and Wiley Cochrane databases through August 31, 2016, for observational studies reporting mortality among adult patients with CRKP and CSKP bacteremia. Search terms were related to Klebsiella, carbapenem-resistance, and infection. Studies including fewer than 10 patients per group were excluded. A random-effects model and meta-regression were used to assess the relationship between carbapenem-resistance, appropriateness of IAT, and mortality. RESULTS Mortality was higher in patients who had CRKP bacteremia than in patients with CSKP bacteremia (15 studies; 1,019 CRKP and 1,148 CSKP patients; unadjusted odds ratio [OR], 2.2; 95% confidence interval [CI], 1.8-2.6; I-2=0). Mortality was lower in patients with appropriate IAT than in those without appropriate IAT (7 studies; 658 patients; unadjusted OR, 0.5; 95% CI, 0.3-0.8; I-2=36%). CRKP patients (11 studies; 1,326 patients; 8-year period) were consistently less likely to receive appropriate IAT (unadjusted OR, 0.5; 95% CI, 0.3-0.7; I-2=43%). Our meta-regression analysis identified a significant association between the difference in appropriate IAT and mortality (OR per 10% difference in IAT, 1.3; 95% CI, 1.0-1.6). CONCLUSIONS Appropriateness of IAT is an important contributor to the observed difference in mortality between patients with CRKP bacteremia and patients with CSKP bacteremia. Infect Control Hosp Epidemiol 2017;38:1319-1328
引用
收藏
页码:1319 / 1328
页数:10
相关论文
共 50 条
  • [1] Klebsiella pneumoniae bacteremia mortality: a systematic review and meta-analysis
    Li, Dan
    Huang, Xiangning
    Rao, Huayun
    Yu, Hua
    Long, Shanshan
    Li, Yulian
    Zhang, Jie
    FRONTIERS IN CELLULAR AND INFECTION MICROBIOLOGY, 2023, 13
  • [2] Systematic review and meta-analysis on the carbapenem-resistant hypervirulent Klebsiella pneumoniae isolates
    Nou, Motahareh Sabaghi Qala
    Amirian, Zahra
    Dehghani, Fatemeh
    Vejdan, Amir-Kazem
    Rooin, Roghayeh
    Dehghanmehr, Sadegh
    BMC PHARMACOLOGY & TOXICOLOGY, 2025, 26 (01)
  • [3] Systematic review and meta-analysis of mortality of patients infected with carbapenem-resistant Klebsiella pneumoniae
    Xu, Liangfei
    Sun, Xiaoxi
    Ma, Xiaoling
    ANNALS OF CLINICAL MICROBIOLOGY AND ANTIMICROBIALS, 2017, 16
  • [4] Predictors of mortality in patients with carbapenem-resistant Klebsiella pneumoniae infection: a meta-analysis and a systematic review
    Qian, Yiyi
    Bi, Yingmin
    Liu, Shuang
    Li, Xiangyu
    Dong, Shuaiyue
    Ju, Mohan
    ANNALS OF PALLIATIVE MEDICINE, 2021, 10 (07) : 7340 - 7350
  • [5] Mortality, clinical and microbiological response following antibiotic therapy among patients with carbapenem-resistant Klebsiella pneumoniae infections (a meta-analysis dataset)
    Agyeman, Akosua A.
    Bergen, Phillip J.
    Rao, Gauri G.
    Nation, Roger L.
    Landersdorfer, Cornelia B.
    DATA IN BRIEF, 2020, 28
  • [6] Impact of carbapenem resistance on mortality in patients infected with Enterobacteriaceae: a systematic review and meta-analysis
    Zhou, Ruyin
    Fang, Xiangming
    Zhang, Jinjin
    Zheng, Xiaodong
    Shangguan, Shuangyue
    Chen, Shibo
    Shen, Yingbo
    Liu, Zhihai
    Li, Juan
    Zhang, Rong
    Shen, Jianzhong
    Walsh, Timothy R.
    Wang, Yang
    BMJ OPEN, 2021, 11 (12):
  • [7] Relationship between antibiotic exposure and carbapenem-resistant Klebsiella pneumoniae infection within four types of control patients: A systematic review and meta-analysis
    Zhu, Lin
    Liang, Le
    Hui, Jiaojiao
    Lu, Jian
    Yang, Rui
    He, Qingqing
    Tian, Nani
    Bai, Ting
    Li, Xiao
    JOURNAL OF GLOBAL ANTIMICROBIAL RESISTANCE, 2023, 33 : 137 - 151
  • [8] The Impact of Carbapenem Resistance on Mortality in Patients With Klebsiella Pneumoniae Bloodstream Infection: An Individual Patient Data Meta-Analysis of 1952 Patients
    Maraolo, Alberto E.
    Corcione, Silvia
    Grossi, Adriano
    Signori, Alessio
    Alicino, Cristiano
    Hussein, Khetam
    Trecarichi, Enrico M.
    Viale, Pierluigi
    Timsit, Jean-Francois
    Veeraraghavan, Balaji
    Villegas, Maria V.
    Rahav, Galia
    Daikos, George L.
    Vardakas, Konstantinos Z.
    Roilides, Emmanuel
    Uhlemann, Anne-Catrin
    Ghafur, Abdul K.
    Pinna, Simone Mornese
    Bassetti, Matteo
    Kohler, Philipp P.
    Giacobbe, Daniele R.
    INFECTIOUS DISEASES AND THERAPY, 2021, 10 (01) : 541 - 558
  • [9] Association Between Carbapenem Resistance and Mortality Among Adult, Hospitalized Patients With Serious Infections Due to Enterobacteriaceae: Results of a Systematic Literature Review and Meta-analysis
    Martin, Amber
    Fahrbach, Kyle
    Zhao, Qi
    Lodise, Thomas
    OPEN FORUM INFECTIOUS DISEASES, 2018, 5 (07):
  • [10] Monotherapy vs combination therapy in patients with Klebsiella pneumoniae bloodstream infection: A systematic review and meta-analysis
    Li, Dan
    Rao, Huayun
    Xu, Yi
    Zhang, Min
    Zhang, Jie
    Luo, Jianrong
    JOURNAL OF INFECTION AND CHEMOTHERAPY, 2024, 30 (05) : 372 - 378